Major in Medical Technology

Labopharm files New Drug Submission with Health Canada for novel antidepressant

... multi-centre Phase III study in patients with major unipolar depressive disorder demonstrated the ... (Volume 6, Number 5) ( www.psychiatrymmc.com ). major depressive disorder (MDD) is a common mental ... Approximately 8% of adults will experience major depression at some time in their lives. ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

... in New Jersey. Mayor Bloomberg is a major supporter of the move. "New York City has always ... that our work is paying off. It also serves as a major boost to our efforts to diversify New York City's ... K. Rowinsky, M.D. "Gastric cancer is not only a major cause of mortality and morbidity in Asia, but the ...

University of Michigan Study Shows SEQUENOM's MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test

... particularly the potential to close the last major gap in screening for cervical cancer and thus ... SEQUENOM will continue to collaborate with major medical centers to further validate and ... Company's plans to continue to collaborate with major medical centers to further validate and ...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

... most common type of cardiac arrhythmia, and is a major risk factor for stroke. Because AF is often ... of deCODE AF(TM), at the heart of which is the major AF and stroke variant discovered by deCODE on ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ...

deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia

... SNPs are located very closely together in the major Histocompatibility Complex, a region on ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ... for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer, for ...

Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled

... of the company's VerifyNow P2Y12 Test, reduces major cardiovascular adverse events (e.g., heart ... company's VerifyNow System and P2Y12 Test reduces major cardiovascular adverse events post-PCI. The ... to multiple antiplatelet agents. Addressing every major antiplatelet drug, including EC-cleared product ...

Mayo Clinic Proceedings Reviews Deep Brain Stimulation to Treat Psychiatric Diseases

... pain receptors. In the developed world, major depression is second only to cardiovascular ... illness in the United States. The prevalence of major depression, known to be a chronic and relapsing ... therapy can effectively treat many patients with major depression; however, up to 20 percent of these ...

AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain

... Study in major abdominal surgery patients achieved primary and ... for management of post-operative pain following major abdominal surgery reported statistically ... study included 88 patients undergoing major abdominal surgery randomized to receive either 10 ...

Research: Popular Diabetes Medications Associated with Increase in Bone Fractures

... issues. Troglitazone, the third of three major drugs in the TZD class, was withdrawn from the ... Study (CMOS) has revealed an increased risk for major cardiovascular events in patients with diabetes ... together, nearly 27 percent experienced a major cardiovascular event within the first 12 months ...

Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research

... Stand Up To Cancer Garners Broad Support major League Baseball was the first major donor to contribute to Stand Up To Cancer. ... heritage, and it has been a privilege for major League Baseball to join the Stand Up To Cancer ...

Ridge Diagnostics, Inc. Clinical Data on Blood Test for Depression Presented at American Psychiatric Association Annual Meeting

... its first-in-class, proprietary blood test for major Depressive Disorder(MDD), will be presented ... to Aid in Diagnosis, Treatment and Management of major Depressive Disorder, at the American Psychiatric ... for the diagnosis and treatment monitoring of major Depressive Disorder (MDD). The company's ...

BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available

... percentage of products purchased from each major supplier), and plan a long-term strategy to ... includes detailed market share estimates across major stem cell product categories by market segment, ... particular, what differentiated cell types are of major interest. Although it may not come as a surprise ...

New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel

... also showed that rates on non-CABG-related TIMI major or minor bleeding did not significantly differ by ... versus 12.1 percent), with an increased risk of major bleeding by 32 percent compared with clopidogrel ... deaths in the EU each year.(5) Heart attack is a major manifestation of coronary heart disease, which ...

Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic Assays

... 2008, presence of JAK2 V617F is now one of the major criteria in the diagnostic algorithm for MPN. ... hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and government facilities, and major clinics. In addition, ARUP is a worldwide ...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

... with the added benefits of weight loss and no major hypoglycemia, could provide patients with an ... due to nausea in each treatment arm. There was no major hypoglycemia in any treatment group. The most ... companies plan to present the full data set at a major medical meeting and submit the data for ...

Schering-Plough Announces Results of the Early ACS Trial

... group, with 118 patients experiencing a TIMI major bleeding event, compared to 83 in the delayed ... controlled on antihypertensive therapy; major surgery within the preceding six weeks; history ... PCI, INTEGRILIN is associated with an increase in major and minor bleeding at the site of arterial sheath ...

Medgenics' Phase I/II Clinical Trial Now Shows EPODURE Continuous Anemia Treatment Lasting 5 Months in Kidney Disease Patients

... The Company's active discussions with major potential strategic partners have expanded since ... market via multiple strategic partnerships with major pharmaceutical and/or medical device companies, ... 2000, Medgenics is a US-incorporated company with major operations in Misgav, Israel. Medgenics was ...

First Year Results of the AXA Research Fund: Over Euro 13 Million Allocated for Research in 2008

... is to promote the understanding and prevention of major risks in the world by supporting cutting edge ... Euro 100 million over five years, making it a major initiative in the realm of scientific ... Project on the impact of climate change on major flooding in Europe (Institute for Meteorology in ...

Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study

... Antiplatelet Agent Showed No Increase in TIMI major and Minor Bleeding and was Well Tolerated When ... and tolerability. TRA showed no increase in major and minor Thrombolysis in Myocardial Infarction ... was measured using the TIMI bleeding scale. TIMI major bleeding is defined as any intracranial (head) ...

Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease

... Our results thus far appear to offer a major advantage over current therapies and to represent ... multiple sclerosis. The technology represents a major advancement over today's protein therapy which ... space. The Company is in active discussions with major potential strategic partners for one or more ...

Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study

... 40 years of age without a current diagnosis of major depressive disorder; with no confounding painful ... States for the acute and maintenance treatment of major depressive disorder, the acute treatment of ... Information Cymbalta is approved to treat major depressive disorder and generalized anxiety ...

British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection

... University of Nottingham Scientists Leading major Study into Lethal 'Super' Strains of C.difficile ... at The University of Nottingham are leading a major European study to unravel the genetic code of one ... to HAI research. Researchers in CHAI have made major breakthroughs in our understanding of the basic ...

A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer

... the world of common SNPs conferring risk of many major types of cancer. Yet without exception, these ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ... for prostate cancer; deCODE Glaucoma(TM) for a major type of glaucoma; and deCODE BreastCancer(TM), ...

ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development in Osteoarthritis with the Potential for Disease-Modifying Activity

... By that, inhibiting TNF alpha can address the major aspects of OA therapy: signs and symptoms and ... in inflammation, and has been identified as a major contributor to pain (signs and symptoms) and ... Similar numbers are seen in Europe and other major markets. Peter Lichtlen, M.D., Ph.D., Head ...

ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease

... treatment of back of the eye disease, and is a major milestone in ThromboGenics' corporate ... with a much poorer prognosis in certain major eye indications, including diabetic retinopathy ... a simple one-off procedure, removing the need for major eye surgery with its associated risks and costs ...

Major deCODE-led Study Underscores Role of the Brain in Obesity

... in industrialized countries. Obesity is a major risk factor for diseases such as type 2 diabetes, ... diet, eating habits and lack of exercise play a major role, but these interact with genetic factors ... in the genome (SNPs) conferring increased risk of major public health challenges from cardiovascular ...

Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer

... medications in preventing blood clots: following major orthopedic surgery; in patients with atrial ... a type of blood clot that typically forms in a major vein of the leg, and pulmonary embolism, which ... death of possible thromboembolic origin). major bleeding was the main safety parameter. ...

New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation

... as compared to warfarin. While the incidence of major and clinically relevant non-major bleeding events ... and/or bilirubin. Secondary endpoints included major adverse cardiovascular events, stroke, systemic ... or cardiovascular death. The incidence of major and clinically relevant non-major bleeding ...

More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies

... key organs - New long-term data from major independent breast cancer trial at SABCS to ... New data, presented in an oral session, from major international BIG 1-98 trial evaluating Femara ... Low Rate of Transformation and Increased Rate of major Molecular Response in Patients with Newly ...

Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis

... h82a7q. Alcoholic hepatitis is a major cause of morbidity and mortality worldwide. ... more than double that of the placebo group. The major cause was an increased rate of infections. ... show that alcoholic liver disease is still the major cause of liver disease and liver-related death," ...

PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S.

... FDA approval of the IDE supplement is another major milestone on our path forward to commercializing ... Contrast-Induced Nephropathy, or CIN, is a major and growing problem due to the increasing number ... and increases in long-term mortality rates, major in-hospital adverse cardiac events, and the risk ...

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study

... calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study ... was no difference between treatment groups for major adverse events, including cancer or myopathy. ... the risk of heart attack, stroke and other major cardiovascular events in patients with low to ...

NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute

... FSHD since graduating from college. Another major collaborator will be Acceleron Pharma, a biotech ... among top leading research centers." "Indeed, a major goal of ours is to make the work we do here ... and improved genetic testing for FSHD." Its major characteristic is weakening of the skeletal ...

Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation

... complications of atrial fibrillation, and a major cause of death and long-term disability, ... independent risk factors for stroke. Stroke is a major public health problem because this acute event ... patients bedridden. Atrial fibrillation is a major cause of hospitalization and mortality and ...

Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel

... stroke by 19 percent, with an increased risk of major bleeding compared with clopidogrel (2.4 percent vs. 1.8 percent).(2) Heart attacks are a major manifestation of coronary heart disease, a global ... deaths in the EU each year.(6) Heart attack is a major manifestation of coronary heart disease, which ...

Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation

... complications of atrial fibrillation, and a major cause of death and long-term disability, ... independent risk factors for stroke. Stroke is a major public health problem because this acute event ... patients bedridden. Atrial fibrillation is a major cause of hospitalisation and mortality and ...

Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

... 1,000 people treated, there were six more TIMI major bleeding events, but 23 fewer heart attacks in ... among patients with at least one TIMI non-CABG major or minor bleeding (17 in the prasugrel group and ... of discontinuation following an initial major bleeding event, which were similar among those ...

Body Contouring Surgery Risk Rises with Increased Body Mass Index

... >41). Complications were recorded into minor and major categories: minor complications included ... or blood (hematoma) in or around the wound; major complications included any wound requiring ... of the ideal group experienced either minor or major complications, as compared to six in the ...

deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia

... Iceland, July 30 /PRNewswire-FirstCall/ -- In a major paper published today in the online edition of ... enabled us to isolate key genes contributing to major public health challenges from cardiovascular ... prostate cancer; and deCODE Glaucoma(TM) for a major type of glaucoma. deCODE is delivering on the ...

BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union

... relaxant binding agent (SRBA) and the first major pharmaceutical advance in the field of anesthesia ... Research Institute. "This is the first major approval of a product from our combination with ... relaxant binding agent (SRBA), is the first major pharmaceutical advance in the field of anesthesia ...